You are here

Article info

Article menu
Immunotherapy biomarkers
Original research
Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy

Authors

  • Akhilesh Mishra The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USADepartment of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Kuldeep Gupta The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Dhiraj Kumar The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Gabriela Lofland The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Ajay Kumar Sharma The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Lilja B Solnes The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Steven P Rowe The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Patrick M Forde Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Martin G Pomper The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USADepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USADepartment of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Edward W Gabrielson Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USADepartment of Pathology, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Sridhar Nimmagadda The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USADepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USADepartment of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, Maryland, USADepartment of Medicine (Clinical Pharmacology), Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles

Citation

Mishra A, Gupta K, Kumar D, et al
Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy
Journal for ImmunoTherapy of Cancer 2023;11:e007535. doi: 10.1136/jitc-2023-007535
Online issue publication 
October 04, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.